Linaclotide

Abbreviation
Not Applicable
Disease(s)
Irritable Bowl Syndrome
Background
.pdf
Patent oppositions filed in
Argentina

Linaclotide is a peptide family drug comprising 14 amino acid peptide which acts in the intestinal lumen on guanylate cyclase-C (GC-C). It is used in the treatment of Irritable Bowl Syndrome (IBS).

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Argentina17-12-2021CILFAPre-GrantUnder ExaminationFormulationsAR118601A2View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top